Literature DB >> 952733

Systemic use of a new retinoid with and without local dithranol treatment in generalized psoriasis.

C E Orfanos, U Runne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952733     DOI: 10.1111/j.1365-2133.1976.tb15541.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  Inhibition of plasma membrane NADH oxidase activity and growth of HeLa cells by natural and synthetic retinoids.

Authors:  S Dai; D J Morré; C C Geilen; B Almond-Roesler; C E Orfanos; D M Morré
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

2.  Therapy of psoriasis with retinoid plus PUVA: clinical and histologic data.

Authors:  G Heidbreder; E Christophers
Journal:  Arch Dermatol Res       Date:  1979-05-04       Impact factor: 3.017

Review 3.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

Review 4.  Psoriasis. A review of recent advances in treatment.

Authors:  E M Farber; L Nall
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

5.  Epidermal changes induced by oral excess of aromatic retinoid in guinea pigs.

Authors:  D Tsambaos; G Mahrle; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  [Oral treatment with tretinoin: andrological, trichological, ophthalmological findings and effects on acne (author's transl)].

Authors:  G Plewig; W B Schill; C Hofmann
Journal:  Arch Dermatol Res       Date:  1979-05-29       Impact factor: 3.017

Review 7.  Psoriasis therapy: a current perspective.

Authors:  N J Lowe
Journal:  West J Med       Date:  1983-08

8.  [Beneficial effect of oral retinoid in psoriatic hyperproliferation. Autoradiographic studies on involved and non involved skin (author's transl)].

Authors:  E Dierlich; C E Orfanos; H Pullmann; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1979-03-31       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.